SARS-CoV-2 Nucleoprotein, 226-234

Description:

This peptide is derived from severe acute respiratory syndrome coronavirus 2(SARS-Cov-2), Nucleoprotein(Uniprot No: P0DTC9). Antigen Peptide RLNQLESKM, probable allele specificity HLA-A*02:01, for stimulation of antigen-specific T cells in T cell assays.

Sequence:

RLNQLESKM

General

References

Comments (0)

Name	SARS-CoV-2 Nucleoprotein, 226-234
Category	COVID-19
One Letter Code	RLNQLESKM
Three Letter Code	{ARG}{LEU}{ASN}{GLN}{LEU}{GLU}{SER}{LYS}{MET}
Molecular Weight	1118.310
Application	T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response

1. Grifoni, Alba, et al. "A sequence homology and bioinformatic approach can predict candidate targets for immune responses to SARS-CoV-2." Cell host & microbe (2020).